The Frontiers Statistical Editors oversee and ensure validity of statistical methods and analyses of data that are part of research articles submitted to any of the Frontiers medical journals for publication. Articles submitted to a Frontiers medical journal in which concerns about data validity are raised by reviewers or editors will undergo a statistical evaluation by a member of the board. He or she will report on the manuscript containing an assessment of the validity of data, flaws and errors in study design, statistical methods, and analyses will be forwarded to the Handling Editor.
Statistical Editors General Statistics
Bo Zhang, Food and Drug Administration, Silver Spring, USA
Terri Kang Johnson, Food and Drug Administration, Silver Spring, USA Bastian Geelhoed, University Medical Center Groningen (UMCG), Netherlands Min Annie Lin, Food and Drug Administration (FDA), USA Yingchen Wang, University of North Carolina, USA Yiling J Cheng, Centers for Disease Control and Prevention, USA Genetics Mehmet Tevfik Dorak, Liverpool Hope University, United Kingdom Sarah Pulit, UMC Utrecht, Netherlands Clinical Trials Ding Keyue, Queen’s University, Canada Xin Cindy Gao, Food and Drug Administration, Silver Spring, USA Epidemiology Cristian Ricci, Regensburg University, Germany Giovanni Veronesi, University of Insubria, Varese, Italy For more information please visit Frontiers in Cardiovascular Medicine
Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pinterest (Opens in new window)MoreClick to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window)
Like this:Like Loading…
Statistical Editors General Statistics
Bo Zhang, Food and Drug Administration, Silver Spring, USA
Terri Kang Johnson, Food and Drug Administration, Silver Spring, USA Bastian Geelhoed, University Medical Center Groningen (UMCG), Netherlands Min Annie Lin, Food and Drug Administration (FDA), USA Yingchen Wang, University of North Carolina, USA Yiling J Cheng, Centers for Disease Control and Prevention, USA Genetics Mehmet Tevfik Dorak, Liverpool Hope University, United Kingdom Sarah Pulit, UMC Utrecht, Netherlands Clinical Trials Ding Keyue, Queen’s University, Canada Xin Cindy Gao, Food and Drug Administration, Silver Spring, USA Epidemiology Cristian Ricci, Regensburg University, Germany Giovanni Veronesi, University of Insubria, Varese, Italy For more information please visit Frontiers in Cardiovascular Medicine
Statistical Editors
General Statistics
Bo Zhang, Food and Drug Administration, Silver Spring, USA
Terri Kang Johnson, Food and Drug Administration, Silver Spring, USA
Bastian Geelhoed, University Medical Center Groningen (UMCG), Netherlands
Min Annie Lin, Food and Drug Administration (FDA), USA
Yingchen Wang, University of North Carolina, USA
Yiling J Cheng, Centers for Disease Control and Prevention, USA
Genetics
Mehmet Tevfik Dorak, Liverpool Hope University, United Kingdom
Sarah Pulit, UMC Utrecht, Netherlands
Clinical Trials
Ding Keyue, Queen’s University, Canada
Xin Cindy Gao, Food and Drug Administration, Silver Spring, USA
Epidemiology
Cristian Ricci, Regensburg University, Germany
Giovanni Veronesi, University of Insubria, Varese, Italy
For more information please visit Frontiers in Cardiovascular Medicine
